226 related articles for article (PubMed ID: 16683163)
21. WNKs: protein kinases with a unique kinase domain.
Huang CL; Cha SK; Wang HR; Xie J; Cobb MH
Exp Mol Med; 2007 Oct; 39(5):565-73. PubMed ID: 18059132
[TBL] [Abstract][Full Text] [Related]
22. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation.
Achard JM; Warnock DG; Disse-Nicodème S; Fiquet-Kempf B; Corvol P; Fournier A; Jeunemaitre X
Am J Med; 2003 Apr; 114(6):495-8. PubMed ID: 12727582
[No Abstract] [Full Text] [Related]
23. Properties of WNK1 and implications for other family members.
Lenertz LY; Lee BH; Min X; Xu BE; Wedin K; Earnest S; Goldsmith EJ; Cobb MH
J Biol Chem; 2005 Jul; 280(29):26653-8. PubMed ID: 15883153
[TBL] [Abstract][Full Text] [Related]
24. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
25. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
Sohara E; Uchida S
Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
[TBL] [Abstract][Full Text] [Related]
26. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
[TBL] [Abstract][Full Text] [Related]
27. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.
Kokubo Y; Kamide K; Inamoto N; Tanaka C; Banno M; Takiuchi S; Kawano Y; Tomoike H; Miyata T
J Hum Genet; 2004; 49(9):507-515. PubMed ID: 15309683
[TBL] [Abstract][Full Text] [Related]
28. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.
Liu Z; Wang HR; Huang CL
J Biol Chem; 2009 May; 284(18):12198-206. PubMed ID: 19244242
[TBL] [Abstract][Full Text] [Related]
29. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
32. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
[TBL] [Abstract][Full Text] [Related]
33. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
[TBL] [Abstract][Full Text] [Related]
34. A unifying mechanism for WNK kinase regulation of sodium-chloride cotransporter.
Huang CL; Cheng CJ
Pflugers Arch; 2015 Nov; 467(11):2235-41. PubMed ID: 25904388
[TBL] [Abstract][Full Text] [Related]
35. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
[TBL] [Abstract][Full Text] [Related]
36. WNK1 and WNK4 modulate CFTR activity.
Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH
Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447
[TBL] [Abstract][Full Text] [Related]
37. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
Yang CL; Zhu X; Ellison DH
J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
[TBL] [Abstract][Full Text] [Related]
38. Comparison of WNK4 and WNK1 kinase and inhibiting activities.
Wang Z; Yang CL; Ellison DH
Biochem Biophys Res Commun; 2004 May; 317(3):939-44. PubMed ID: 15081430
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
Wilson FH; Kahle KT; Sabath E; Lalioti MD; Rapson AK; Hoover RS; Hebert SC; Gamba G; Lifton RP
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):680-4. PubMed ID: 12515852
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]